β3 adrenoceptor agonist mirabegron protects against right ventricular remodeling and drives Drp1 inhibition.
Journal Information
Full Title: Cardiovasc Diagn Ther
Abbreviation: Cardiovasc Diagn Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Cardiac & Cardiovascular Systems
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-22-274/coif). The authors have no conflicts of interest to declare."
"Funding: This study was supported by the Natural Science Foundation Project of Hunan province, China (grant No. 2020JJ4634), and the National Natural Science Foundation of China (grant No. 82000058)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025